Viewing StudyNCT00254254



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00254254
Status: COMPLETED
Last Update Posted: 2015-02-23
First Post: 2005-11-14

Brief Title: A Study to Evaluate the Pharmacokinetics Pharmacodynamics and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Type 2 Diabetes Mellitus
Keywords:
Name View
Lilly View
diabetes View
adolescents View
exenatide View
Amylin View